EMPERY ASSET MANAGEMENT, LP

Company

Armata Pharmaceuticals, Inc.

Filed

June 6, 2016

Accession Number

0000902664-16-007262

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →